[1] 王立燕,徐若男,韩根成,等.实验性败血症小鼠模型的建立及评价[J].中国实验血液学杂志,2010,18(3):766.
[2] 葛均波.内科学[M].北京:人民卫生出版社,2013:425.
[3] 金伯泉.细胞和分子免疫学[M].北京:科学出版社,2011:253.
[4] 石增立,刘凤,于小玲,等.败血症大鼠促炎性细胞因子与炎性细胞变化的实验研究[J].滨州医学院学报,2004,27(4):241.
[5] KIYOSHI H,KAMRAN G,XIANG PY,et al.Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the ligand PD-L1[J].Immunity,2012,(6):543.
[6] KOLLS JK,LINDÉNA.Interleukin-17 family members and inflammation[J].Immunity,2004,21(4):467.
[7] FOSSIEZ F.T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines[J].Exp Med,2012,183(15):2593.
[8] AHJOKU AO,YU CR,LIU XB,et al.TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/Stat-1[J].Nat Med,2007,13(6):711.
[9] WONG CK,HO CY,LI EK,et al.Elevation of proinflammatory cytokine (IL-18,IL-17,IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematos us[J].Lupus,2000,9(8):589.
[10] LOONG CC,HSIEH HG,LUI WY,et al.Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection[J].J Pathol,2002,197(3):322.
[11] ROMANO H,SIRONI M,TONIATI C,et al.Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment[J].Immunity,2012,6(11):315.
[12] 王会会,陈国江,黎燕,等.补体C5a、C5a受体及其拮抗剂的研究进展[J].国际药学研究杂志,2010,37(3):181.
[13] 何维.医学免疫学[M].北京:人民卫生出版社,2011:76.
[14] 胡荣,左大鹏,梁瑞彬,等.败血症动物模型中胸腺细胞凋亡及TNF-α作用的研究[J].中华微生物学和免疫学杂志,2000,20(2):113.
[15] GU D,XIONG L,HAN Y,et al.Transfusion of necrotic cells redresses regulatory T cell and Th17 cell imbalance in septic mice[J].Nan Fang Yi Ke Da Xue Xue Bao,2014,34(7):956.
[16] 施荣,王倩,韩丹,等.炎调方抑制LPS诱导人肺泡上皮细胞炎症因子释放机制研究[J].中国中医急症,2016,25(4):572.
[17] 荆喜中,贾欢欢,罗挺,等.小鼠脓毒症模型的建立和评价[J].中国实验动物学报,2016,24(2):158.
[18] SCHABBAUAR G.Polymicrobial sepsis models:CLP versus CASP[J].Drug Discov Today Dis Mod,2012,9(1):17.